$ Value
$2.3M
Shares
50,000
Price
$45
Filed
Aug 20
Insider
Name
Dudum Andrew
Title
Chief Executive Officer
CIK
0001837796
Roles
Transaction Details
Transaction Date
2025-08-18
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
106,188
Footnotes
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.76 - $45.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.85 - $45.15. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.95 - $45.39. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.68 - $45.43. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.69 - $45.40. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.65 - $45.35. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | This amount reflects an annuity payment-in-kind of 26,461 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT. | This amount reflects an annuity payment-in-kind of 26,461 shares of Class A Common Stock from the AD 2022 GRAT to the Andrew Dudum 2015 Trust dated July 2, 2015. | Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. | The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.
Filing Info
Dudum Andrew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-09 | HIMS | G | — |
| 2026-04-09 | HIMS | G | — |
| 2026-03-13 | HIMS | F | $10.8M |
| 2026-03-13 | HIMS | M | — |
| 2026-03-13 | HIMS | F | $2.2M |
| 2026-03-13 | HIMS | M | $0 |
| 2026-03-13 | HIMS | M | $0 |
| 2026-03-13 | HIMS | M | $0 |
| 2026-03-13 | HIMS | M | $0 |
| 2026-03-11 | HIMS | A | $0 |
Other Insiders at HIMS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Dudum Andrew
Chief Executive Officer
|
— | — | 2026-04-09 |
|
Boughton Soleil
Chief Legal Officer
|
— | $473K | 2026-04-20 |
|
Carroll Patrick Harrison
Chief Medical Officer
|
— | — | 2026-03-13 |
|
Autor Deborah M.
Chief Policy Officer
|
— | — | 2026-03-13 |
|
Becklund Irene
PAO
|
— | $137K | 2026-03-17 |
|
Okupe Oluyemi
Chief Financial Officer
|
— | $2.5M | 2026-04-20 |
|
Chi Michael
Chief Operating Officer
|
— | $2.4M | 2026-03-17 |
| Pendarvis Christiane | — | — | 2026-03-13 |
|
Elshenawy Mohamed
CTO
|
— | — | 2026-03-11 |